(Q45022631)

8 December 2017

0 references

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis (English)

1 reference

attention deficit hyperactivity disorder

8 December 2017

main subject

0 references

1 reference

1 reference

Josep Antoni Ramos-Quiroga

2

1 reference

8 December 2017

6

1 reference

8 December 2017

Rosa Bosch

4

0 references

author name string

Xavier Castells

1

1 reference

8 December 2017

David Rigau

3

1 reference

8 December 2017

Mariana Nogueira

5

1 reference

8 December 2017

Miguel Casas

7

1 reference

8 December 2017

publication date

1 February 2011

1 reference

8 December 2017

1 reference

8 December 2017

volume

25

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

157-169

1 reference

https://scigraph.springernature.com/pub.10.2165/11539440-000000000-00000

8 December 2017

exact match

0 references

cites work

Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults

1 reference

12 December 2020

Comparing the efficacy of medications for ADHD using meta-analysis

1 reference

12 December 2020

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

1 reference

12 December 2020

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

1 reference

12 December 2020

Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?

1 reference

12 December 2020

Effectiveness outcomes in attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

1 reference

12 December 2020

Extended-release methylphenidate (Ritalin LA).

1 reference

12 December 2020

Attention deficit disorders in adults.

1 reference

12 December 2020

Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder

1 reference

12 December 2020

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Treatment strategies for co-occurring ADHD and substance use disorders

1 reference

12 December 2020

Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain

1 reference

12 December 2020

Why sources of heterogeneity in meta-analysis should be investigated

1 reference

12 December 2020

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

1 reference

12 December 2020

Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.

1 reference

12 December 2020

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

12 December 2020

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

1 reference

12 December 2020

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

1 reference

12 December 2020

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

1 reference

12 December 2020

Methylphenidate bioavailability from two extended-release formulations

1 reference

12 December 2020

Meta-analyses involving cross-over trials: methodological issues

1 reference

12 December 2020

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

12 December 2020

The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults with Attention-Deficit Hyperactivity Disorder

1 reference

12 December 2020

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children

1 reference

12 December 2020

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

1 reference

12 December 2020

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

1 reference

12 December 2020

A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults

1 reference

12 December 2020

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.

1 reference

12 December 2020

3-Year Follow-up of the NIMH MTA Study

1 reference

12 December 2020

Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study

1 reference

12 December 2020

A simple method for converting an odds ratio to effect size for use in meta-analysis

1 reference

12 December 2020

Attention-Deficit/Hyperactivity Disorder in Adults

1 reference

12 December 2020

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Meta-analysis. Beyond the grand mean?

1 reference

12 December 2020

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

1 reference

12 December 2020

Efficacy of stimulants in adult ADHD.

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

12 December 2020

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration

1 reference

12 December 2020

An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

1 reference

12 December 2020

Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence

1 reference

12 December 2020

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis.

1 reference

12 December 2020

Methylphenidate effects on symptoms of attention deficit disorder in adults.

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation

1 reference

12 December 2020

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

1 reference

12 December 2020

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.

1 reference

12 December 2020

Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting

1 reference

12 December 2020

10.2165/11539440-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1051044588

0 references

Fatcat ID

release_w5fe2wgn6fbhxm7y7lnn3azpwa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w5fe2wgn6fbhxm7y7lnn3azpwa

24 November 2022

mapped directly with Wikidata item

1 reference